Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Polyxanthylic and Polyguanylic Acid Inhibition of Murine Leukemia Virus Activities

S. K. ARYA, T. L. HELSER, W. A. CARTER and P. O. P. Ts’o
Molecular Pharmacology September 1976, 12 (5) 844-853;
S. K. ARYA
Department of Medical Viral Oncology, Roswell Park Memorial Institute, and Graduate Faculty in Microbiology, State University of New York at Buffalo, Roswell Park Division, Buffalo, New York 14263
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. L. HELSER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. A. CARTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. O. P. Ts’o
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Single-stranded polyribonucleotides inhibit the replication of murine leukemia virus (MuLV) in cultured cells. Our previous studies suggested that (a) purine polyribonucleotides may be more potent than pyrimidine polyribonucleotides, and (b) the inhibitory potency depends on the functional groups on the pyrimidine ring. In our earlier studies, a set of polyribonucleotides was not available which differed only in their purine as opposed to pyrimidine base; thus we could not clearly differentiate the effect of the base from that of the functional groups on the ring system. Poly(xanthylic acid) now provides the means to accomplish this. It is a purine polyribonucleotide with the same functional groups as poly(uridylic acid), a pyrimidine polyribonucleotide. Similarly, poly(guanylic acid) can be compared with poly(cytidylic acid), although the disposition of the functional groups is not identical in this case. We now report that poly(xanthylic acid) is, in fact, 2-3 times more potent than poly(uridylic acid) as an inhibitor of MuLV replication, and poly(guanylic acid) is similarly more potent than poly(cytidylic acid). Neither poly(xanthylic acid) nor poly(guanylic acid) significantly affects the growth rates of cultured host cells; thus their inhibition is apparently not related to any general cytotoxicity. Poly(xanthylic acid) as well as poly(guanylic acid) strongly inhibits MuLV-associated, RNA-directed DNA polymerase in vitro. They also inhibit host cell DNA polymerase activities in vitro, but analysis of inhibition kinetics shows that their inhibitor potency for viral DNA polymerase is several times greater than for cell DNA polymerases. These results substantiate our hypothesis that purine polyribonucleotides are more potent than pyrimidine polyribonucleotides. They also support the notion that inhibition of virus replication by polyribonucleotides may be related to their selective inhibition of viral RNA-directed DNA polymerase activity.

ACKNOWLEDGMENTS We thank Ms. C. Hejna and Mr. A. Cairo for technical assistance, and Drs. B. I. Milavetz and J. S. Horoszewicz for providing a partially purified preparation of murine leukemia virus DNA polymerase.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Polyxanthylic and Polyguanylic Acid Inhibition of Murine Leukemia Virus Activities
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Polyxanthylic and Polyguanylic Acid Inhibition of Murine Leukemia Virus Activities

S. K. ARYA, T. L. HELSER, W. A. CARTER and P. O. P. Ts’o
Molecular Pharmacology September 1, 1976, 12 (5) 844-853;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Polyxanthylic and Polyguanylic Acid Inhibition of Murine Leukemia Virus Activities

S. K. ARYA, T. L. HELSER, W. A. CARTER and P. O. P. Ts’o
Molecular Pharmacology September 1, 1976, 12 (5) 844-853;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics